<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03844321</url>
  </required_header>
  <id_info>
    <org_study_id>2017P001648</org_study_id>
    <nct_id>NCT03844321</nct_id>
  </id_info>
  <brief_title>Healthy Mind Healthy You: A Study of Mindfulness</brief_title>
  <official_title>Healthy Mind Healthy You: A Study of Mindfulness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Global Healthy Living Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Genetic Alliance</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>COPD Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Duchenne Registry</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hugo W. Moser Research Institute at Kennedy Krieger, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Accelerated Cure Project for Multiple Sclerosis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Phelan-McDermid Syndrome Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Immune Deficiency Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Most people experience stress at some point in their lives. Stress, especially when severe,&#xD;
      can not only make you feel bad, it can also worsen existing health problems like heart&#xD;
      disease, type 2 diabetes, obesity, high blood pressure, depression, and even cancer. Healthy&#xD;
      Mind, Healthy You is a new study about how mindfulness can help people cope with stress.&#xD;
      Funded by the Patient Centered Outcome Research Institute (PCORI) and involving 19 Patient&#xD;
      Powered Research Networks (PPRNs), Healthy Mind Healthy You will be able to study the effects&#xD;
      of mindfulness on a wide variety of populations and conditions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 27, 2019</start_date>
  <completion_date type="Actual">February 19, 2020</completion_date>
  <primary_completion_date type="Actual">February 19, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Estimated Weekly Change on World Health Organization-5 (WHO-5)</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. We used linear mixed effects models to examine the effect of the interventions on weekly WHO-5 scores. Change = estimated average weekly change during time frame.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estimated Weekly Change on Perceived Stress Scale (PSS)</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The PSS is a 10-item questionnaire that evaluates an individual's experiences of stress in the previous month. Scores range 0-40, with higher scores representing greater perceived stress. Change = estimated average weekly change during time frame.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Depression Short Form</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The PROMIS: Emotional Distress-Depression Short Form is an 8-item questionnaire that measures perceived depressive symptoms over the past week. Scores range 8-40, with higher scores representing more severe depressive symptoms. Change = estimated average weekly change during time frame.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Anxiety Short Form</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The PROMIS: Emotional Distress-Anxiety Short Form is a 4-item questionnaire that measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms. Change = estimated average weekly change during time frame.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Ability to Participate in Social Roles and Activities Short Form</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The PROMIS: Ability to Participate in Social Roles and Activities Short Form is a 4-item questionnaire that measures the perceived ability to perform one's everyday social roles and activities. Scores range 4-20 with higher scores representing fewer limitations (greater abilities). Change = estimated average weekly change during time frame.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated Weekly Change on Five Facet Mindfulness Questionnaire (FFMQ) Abbreviated</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The FFMQ is a 39-item questionnaire that examines five aspects of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Only the questions related to non-judging of inner experience and non-reactivity were administered (15 items total). The total score on these 15 items was used (range: 15-75). Higher scores represent greater mindfulness. Change = estimated average weekly change during time frame.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Age</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Age was self-reported.</description>
  </other_outcome>
  <other_outcome>
    <measure>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Perceived Stress Scale (PSS)</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PSS is a 10-item questionnaire that evaluates an individual's experiences of stress in the previous month. Scores range 0-40, with higher scores representing greater perceived stress.</description>
  </other_outcome>
  <other_outcome>
    <measure>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Depression Short Form (PROMIS: EDD)</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PROMIS: EDD is a 4-item questionnaire that measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms.</description>
  </other_outcome>
  <other_outcome>
    <measure>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Anxiety Short Form (PROMIS: EDA)</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PROMIS: EDA is a 4-item questionnaire that measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms.</description>
  </other_outcome>
  <other_outcome>
    <measure>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Ability to Participate in Social Roles and Activities Short Form (PROMIS: APRA)</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PROMIS: APRA is a 4-item questionnaire that measures the perceived ability to perform one's everyday social roles and activities. Scores range 4-20 with higher scores representing fewer limitations (greater abilities).</description>
  </other_outcome>
  <other_outcome>
    <measure>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Five Facet Mindfulness Questionnaire (FFMQ) Abbreviated</measure>
    <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
    <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The FFMQ is a 39-item questionnaire that examines five aspects of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Only the questions related to non-judging of inner experience and non-reactivity were administered (15 items total). The total score on these 15 items was used (range: 15-75). Higher scores represent greater mindfulness.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4412</enrollment>
  <condition>Stress</condition>
  <arm_group>
    <arm_group_label>Mindfulness-Based Cognitive Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 sessions of online mindfulness-based cognitive therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Brief Mindfulness</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 sessions of online mindfulness therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-Based Cognitive Therapy</intervention_name>
    <description>8 sessions of online mindfulness-based cognitive therapy</description>
    <arm_group_label>Mindfulness-Based Cognitive Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief Mindfulness</intervention_name>
    <description>3 sessions of online mindfulness therapy</description>
    <arm_group_label>Brief Mindfulness</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Must be a member (patient/member of special population or caregiver) of one of the 19&#xD;
             PCORI Patient-Powered Research Networks (PPRN)&#xD;
&#xD;
          -  Must be age 18 or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under the age of 18 years&#xD;
&#xD;
          -  Unable to read, understand, and/or participate in mindfulness exercises&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew A Nierenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 31, 2017</study_first_submitted>
  <study_first_submitted_qc>February 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2019</study_first_posted>
  <results_first_submitted>September 15, 2020</results_first_submitted>
  <results_first_submitted_qc>April 19, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 13, 2021</results_first_posted>
  <last_update_submitted>April 19, 2021</last_update_submitted>
  <last_update_submitted_qc>April 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Andrew A. Nierenberg, MD</investigator_full_name>
    <investigator_title>Director, Dauten Family Center for Bipolar Treatment Innovation</investigator_title>
  </responsible_party>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 19, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/21/NCT03844321/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Individuals from 17 Patient Centered Outcomes Research Institute (PCORI) Patient Powered Research Networks (PPRNs) who were over the age of 18, able to read and understand English, and/or participate in mindfulness exercises were eligible to participate in Healthy Mind Healthy You Study. Participants were recruited through each PPRN. Recruitment for the study occurred from 2/27/2019 to 10/1/2019 and the follow up period ended on 1/31/2020.</recruitment_details>
      <pre_assignment_details>This study was inclusive of all subgroups, with the exception of individuals under the age of 18 or and individuals not able to participate in mindfulness exercises, with broad inclusion and minimal exclusion criteria. Participants' date of birth which was checked for accuracy by the data management system. After consent, participants completed baseline questionnaires on their mindfulness practices in the past, stress, anxiety, well-being, psychosocial functioning and PPRN-specific assessments.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Mindfulness-Based Cognitive Therapy</title>
          <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
        </group>
        <group group_id="P2">
          <title>Brief Mindfulness</title>
          <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2220"/>
                <participants group_id="P2" count="2192"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="579"/>
                <participants group_id="P2" count="533"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1641"/>
                <participants group_id="P2" count="1659"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Mindfulness-Based Cognitive Therapy</title>
          <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
        </group>
        <group group_id="B2">
          <title>Brief Mindfulness</title>
          <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2220"/>
            <count group_id="B2" value="2192"/>
            <count group_id="B3" value="4412"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.95" spread="14.72"/>
                    <measurement group_id="B2" value="54.63" spread="15.05"/>
                    <measurement group_id="B3" value="55.29" spread="14.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <description>Sex Assigned at Birth</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1780"/>
                    <measurement group_id="B2" value="1768"/>
                    <measurement group_id="B3" value="3548"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="429"/>
                    <measurement group_id="B2" value="410"/>
                    <measurement group_id="B3" value="839"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ambiguous</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <description>Gender Identity</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Woman</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1690"/>
                    <measurement group_id="B2" value="1654"/>
                    <measurement group_id="B3" value="3344"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Man</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="402"/>
                    <measurement group_id="B2" value="388"/>
                    <measurement group_id="B3" value="790"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No selected answer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genderqueer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Transgender male/Trans man/Female-to-male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prefer not to answer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Something else</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multiple gender categories</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Transgender female/Trans woman/Male-to-female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <description>Sexual Orientation</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Straight</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1816"/>
                    <measurement group_id="B2" value="1744"/>
                    <measurement group_id="B3" value="3560"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bisexual</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gay</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lesbian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="147"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Queer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No selected answer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prefer not to answer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asexual</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multiple sexual orientations</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Something else</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Questioning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <description>Race/Origin</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1957"/>
                    <measurement group_id="B2" value="1917"/>
                    <measurement group_id="B3" value="3874"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multiple Race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black, African American, African, or AfroCaribbean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No selected answer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prefer not to answer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native American, American Indian, or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <description>Ethnicity</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2078"/>
                    <measurement group_id="B2" value="2042"/>
                    <measurement group_id="B3" value="4120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                    <measurement group_id="B2" value="97"/>
                    <measurement group_id="B3" value="198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No selected answer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prefer not to answer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>World Health Organization-5 Well-Being Index</title>
          <description>This 5-item questionnaire assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.2" spread="20.6"/>
                    <measurement group_id="B2" value="50.6" spread="20.7"/>
                    <measurement group_id="B3" value="50.4" spread="20.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Five Facet Mindfulness Questionnaire</title>
          <description>This 39-item questionnaire examines five aspects of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Only the questions related to non-judging of inner experience and non-reactivity were administered (15 items total). The total score on these 15 items was used (range: 15-75). Higher scores represent greater mindfulness.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.9" spread="11.2"/>
                    <measurement group_id="B2" value="49.9" spread="11.0"/>
                    <measurement group_id="B3" value="49.9" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Perceived Stress Scale</title>
          <description>This 10-item questionnaire evaluates an individual's experiences of stress in the previous month. Scores range 0-40, with higher scores representing greater perceived stress.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.1" spread="3.71"/>
                    <measurement group_id="B2" value="20.2" spread="3.64"/>
                    <measurement group_id="B3" value="20.2" spread="3.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PROMIS Emotional Distress - Anxiety Short Form (Adult, 4-Item)</title>
          <description>This 4-item questionnaire measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.94" spread="3.64"/>
                    <measurement group_id="B2" value="8.98" spread="3.61"/>
                    <measurement group_id="B3" value="8.96" spread="3.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PROMIS Emotional Distress - Depression Short Form (Adult, v. 8a)</title>
          <description>This 8-item questionnaire measured perceived depressive symptoms over the past week. Scores range 8-40, with higher scores representing more severe depressive symptoms.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.4" spread="7.00"/>
                    <measurement group_id="B2" value="16.3" spread="7.07"/>
                    <measurement group_id="B3" value="16.4" spread="7.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PROMIS: Ability to Participate in Social Roles and Activities Short Form (Adult, 4-item)</title>
          <description>This 4-item questionnaire measures the perceived ability to perform one's everyday social roles and activities. Scores range 4-20 with higher scores representing fewer limitations (greater abilities).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.6" spread="4.35"/>
                    <measurement group_id="B2" value="10.6" spread="4.29"/>
                    <measurement group_id="B3" value="10.6" spread="4.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Estimated Weekly Change on World Health Organization-5 (WHO-5)</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. We used linear mixed effects models to examine the effect of the interventions on weekly WHO-5 scores. Change = estimated average weekly change during time frame.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change on World Health Organization-5 (WHO-5)</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. We used linear mixed effects models to examine the effect of the interventions on weekly WHO-5 scores. Change = estimated average weekly change during time frame.</description>
          <units>estimated weekly change in scale score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" lower_limit="0.63" upper_limit="0.93"/>
                    <measurement group_id="O2" value="0.76" lower_limit="0.60" upper_limit="0.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" lower_limit="0.34" upper_limit="0.48"/>
                    <measurement group_id="O2" value="0.33" lower_limit="0.26" upper_limit="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We used a linear mixed effects model to examine the difference in effect of time on weekly WHO-5 scores in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 8 weeks. This model accounts for the covariance of repeated measurements within subjects, and we used maximum likelihood estimation to adjust for missing assessment scores. The model includes a random slope and intercept, and fixed effects for intervention, time, and an intervention by time interaction.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.820</p_value>
            <p_value_desc>A two-sided significance level of 0.05 was used for all analyses.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1607</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>-0.02</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.24</ci_lower_limit>
            <ci_upper_limit>0.19</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We used a linear mixed effects model to examine the difference in effect of time on weekly WHO-5 scores in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 20 weeks. This model accounts for the covariance of repeated measurements within subjects, and we used maximum likelihood estimation to adjust for missing assessment scores. The model includes a random slope and intercept, and fixed effects for intervention, time, and an intervention by time interaction.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.110</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1147</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>-0.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.18</ci_lower_limit>
            <ci_upper_limit>0.02</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimated Weekly Change on Perceived Stress Scale (PSS)</title>
        <description>The PSS is a 10-item questionnaire that evaluates an individual's experiences of stress in the previous month. Scores range 0-40, with higher scores representing greater perceived stress. Change = estimated average weekly change during time frame.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change on Perceived Stress Scale (PSS)</title>
          <description>The PSS is a 10-item questionnaire that evaluates an individual's experiences of stress in the previous month. Scores range 0-40, with higher scores representing greater perceived stress. Change = estimated average weekly change during time frame.</description>
          <units>estimated weekly change in scale score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" lower_limit="-0.16" upper_limit="-0.09"/>
                    <measurement group_id="O2" value="-0.15" lower_limit="-0.18" upper_limit="-0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" lower_limit="-0.09" upper_limit="-0.06"/>
                    <measurement group_id="O2" value="-0.07" lower_limit="-0.08" upper_limit="-0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used a linear mixed effects model to examine the difference in effect of time on weekly PSS scores in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 8 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.284</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df= 1726</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>-0.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.07</ci_lower_limit>
            <ci_upper_limit>0.02</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used a linear mixed effects model to examine the difference in effect of time on weekly PSS scores in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 20 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.394</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1018</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>0.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.01</ci_lower_limit>
            <ci_upper_limit>0.03</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Depression Short Form</title>
        <description>The PROMIS: Emotional Distress-Depression Short Form is an 8-item questionnaire that measures perceived depressive symptoms over the past week. Scores range 8-40, with higher scores representing more severe depressive symptoms. Change = estimated average weekly change during time frame.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Depression Short Form</title>
          <description>The PROMIS: Emotional Distress-Depression Short Form is an 8-item questionnaire that measures perceived depressive symptoms over the past week. Scores range 8-40, with higher scores representing more severe depressive symptoms. Change = estimated average weekly change during time frame.</description>
          <units>estimated weekly change in scale score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.19" lower_limit="-0.23" upper_limit="-0.15"/>
                    <measurement group_id="O2" value="-0.17" lower_limit="-0.21" upper_limit="-0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" lower_limit="-0.13" upper_limit="-0.09"/>
                    <measurement group_id="O2" value="-0.06" lower_limit="-0.08" upper_limit="-0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used a linear mixed effects model to examine the difference in effect of time on weekly PROMIS: Emotional Distress-Depression Short Form scores in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 8 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.431</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1591</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>0.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.04</ci_lower_limit>
            <ci_upper_limit>0.09</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used a linear mixed effects model to examine the difference in effect of time on weekly PROMIS: Emotional Distress-Depression Short Form scores in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 20 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;.001</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1159</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>0.05</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.02</ci_lower_limit>
            <ci_upper_limit>0.08</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Anxiety Short Form</title>
        <description>The PROMIS: Emotional Distress-Anxiety Short Form is a 4-item questionnaire that measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms. Change = estimated average weekly change during time frame.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Anxiety Short Form</title>
          <description>The PROMIS: Emotional Distress-Anxiety Short Form is a 4-item questionnaire that measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms. Change = estimated average weekly change during time frame.</description>
          <units>estimated weekly change in scale score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" lower_limit="-0.15" upper_limit="-0.10"/>
                    <measurement group_id="O2" value="-0.13" lower_limit="-0.16" upper_limit="-0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" lower_limit="-0.08" upper_limit="-0.06"/>
                    <measurement group_id="O2" value="-0.05" lower_limit="-0.06" upper_limit="-0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used a linear mixed effects model to examine the difference in effect of time on weekly PROMIS: Emotional Distress-Anxiety Short Form scores in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 8 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.399</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1601</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>-0.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.05</ci_lower_limit>
            <ci_upper_limit>0.02</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used a linear mixed effects model to examine the difference in effect of time on weekly PROMIS: Emotional Distress-Anxiety Short Form scores in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 20 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.048</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1171</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>0.02</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>0.03</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Ability to Participate in Social Roles and Activities Short Form</title>
        <description>The PROMIS: Ability to Participate in Social Roles and Activities Short Form is a 4-item questionnaire that measures the perceived ability to perform one's everyday social roles and activities. Scores range 4-20 with higher scores representing fewer limitations (greater abilities). Change = estimated average weekly change during time frame.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change on Patient Reported Outcomes Measurement Information System (PROMIS): Ability to Participate in Social Roles and Activities Short Form</title>
          <description>The PROMIS: Ability to Participate in Social Roles and Activities Short Form is a 4-item questionnaire that measures the perceived ability to perform one's everyday social roles and activities. Scores range 4-20 with higher scores representing fewer limitations (greater abilities). Change = estimated average weekly change during time frame.</description>
          <units>estimated weekly change in scale score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" lower_limit="-0.15" upper_limit="-0.09"/>
                    <measurement group_id="O2" value="-0.14" lower_limit="-0.17" upper_limit="-0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" lower_limit="-0.06" upper_limit="-0.04"/>
                    <measurement group_id="O2" value="-0.04" lower_limit="-0.06" upper_limit="-0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used a linear mixed effects model to examine the difference in effect of time on weekly PROMIS: Ability to Participate in Social Roles and Activities Short Form scores (reverse scored) in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 8 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.488</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1560</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>-0.02</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.06</ci_lower_limit>
            <ci_upper_limit>0.03</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used a linear mixed effects model to examine the difference in effect of time on weekly PROMIS: Ability to Participate in Social Roles and Activities Short Form scores (reverse scored) in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 20 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.446</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1179</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>0.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.01</ci_lower_limit>
            <ci_upper_limit>0.03</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimated Weekly Change on Five Facet Mindfulness Questionnaire (FFMQ) Abbreviated</title>
        <description>The FFMQ is a 39-item questionnaire that examines five aspects of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Only the questions related to non-judging of inner experience and non-reactivity were administered (15 items total). The total score on these 15 items was used (range: 15-75). Higher scores represent greater mindfulness. Change = estimated average weekly change during time frame.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change on Five Facet Mindfulness Questionnaire (FFMQ) Abbreviated</title>
          <description>The FFMQ is a 39-item questionnaire that examines five aspects of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Only the questions related to non-judging of inner experience and non-reactivity were administered (15 items total). The total score on these 15 items was used (range: 15-75). Higher scores represent greater mindfulness. Change = estimated average weekly change during time frame.</description>
          <units>estimated weekly change in scale score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.92" lower_limit="0.84" upper_limit="1.00"/>
                    <measurement group_id="O2" value="0.88" lower_limit="0.79" upper_limit="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.43" lower_limit="0.39" upper_limit="0.46"/>
                    <measurement group_id="O2" value="0.37" lower_limit="0.34" upper_limit="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used a linear mixed effects model to examine the difference in effect of time on weekly FFMQ scores in Mindfulness Light vs. Mindfulness-Based Cognitive Therapy conditions from baseline to 8 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.469</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1618</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>-0.04</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.16</ci_lower_limit>
            <ci_upper_limit>0.07</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>As with the primary outcome, we used linear mixed effects models to examine the effect of time on weekly FFMQ scores across both intervention conditions from baseline to 20 weeks.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.033</p_value>
            <p_value_desc>A two-sided significance level of .05 was used.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>df = 1067</method_desc>
            <param_type>Difference in Slopes</param_type>
            <param_value>-0.06</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.11</ci_lower_limit>
            <ci_upper_limit>-0.01</ci_upper_limit>
            <estimate_desc>Slope estimate = difference in slopes between conditions (Mindfulness Light vs. Mindfulness-Based Cognitive Therapy) during time frame.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Age</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Age was self-reported.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Age</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Age was self-reported.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: Age 45</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.98" lower_limit="0.78" upper_limit="1.19"/>
                    <measurement group_id="O2" value="0.75" lower_limit="0.55" upper_limit="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: Age 55</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.81" lower_limit="0.66" upper_limit="0.96"/>
                    <measurement group_id="O2" value="0.73" lower_limit="0.58" upper_limit="0.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: Age 65</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.64" lower_limit="0.48" upper_limit="0.80"/>
                    <measurement group_id="O2" value="0.72" lower_limit="0.54" upper_limit="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Age 45</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" lower_limit="0.43" upper_limit="0.63"/>
                    <measurement group_id="O2" value="0.38" lower_limit="0.29" upper_limit="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Age 55</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" lower_limit="0.36" upper_limit="0.51"/>
                    <measurement group_id="O2" value="0.33" lower_limit="0.25" upper_limit="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Age 65</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" lower_limit="0.27" upper_limit="0.42"/>
                    <measurement group_id="O2" value="0.27" lower_limit="0.19" upper_limit="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Age measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.046</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Age measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.275</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Perceived Stress Scale (PSS)</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PSS is a 10-item questionnaire that evaluates an individual's experiences of stress in the previous month. Scores range 0-40, with higher scores representing greater perceived stress.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Perceived Stress Scale (PSS)</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PSS is a 10-item questionnaire that evaluates an individual's experiences of stress in the previous month. Scores range 0-40, with higher scores representing greater perceived stress.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to Week 8: PSS = 18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.64" lower_limit="0.48" upper_limit="0.80"/>
                    <measurement group_id="O2" value="0.61" lower_limit="0.44" upper_limit="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 8: PSS = 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" lower_limit="0.63" upper_limit="0.93"/>
                    <measurement group_id="O2" value="0.75" lower_limit="0.60" upper_limit="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 8: PSS = 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.92" lower_limit="0.75" upper_limit="1.09"/>
                    <measurement group_id="O2" value="0.89" lower_limit="0.71" upper_limit="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 20: PSS = 18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" lower_limit="0.27" upper_limit="0.42"/>
                    <measurement group_id="O2" value="0.28" lower_limit="0.21" upper_limit="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 20: PSS = 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.42" lower_limit="0.35" upper_limit="0.48"/>
                    <measurement group_id="O2" value="0.33" lower_limit="0.25" upper_limit="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 20: PSS = 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.48" lower_limit="0.40" upper_limit="0.57"/>
                    <measurement group_id="O2" value="0.37" lower_limit="0.28" upper_limit="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PSS measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.977</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PSS measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.341</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Depression Short Form (PROMIS: EDD)</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PROMIS: EDD is a 4-item questionnaire that measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Depression Short Form (PROMIS: EDD)</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PROMIS: EDD is a 4-item questionnaire that measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to Week 8: PROMIS: EDD = 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" lower_limit="0.32" upper_limit="0.70"/>
                    <measurement group_id="O2" value="0.47" lower_limit="0.28" upper_limit="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 8: PROMIS: EDD = 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.72" lower_limit="0.57" upper_limit="0.86"/>
                    <measurement group_id="O2" value="0.69" lower_limit="0.54" upper_limit="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 8: PROMIS: EDD = 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.92" lower_limit="0.75" upper_limit="1.10"/>
                    <measurement group_id="O2" value="0.91" lower_limit="0.73" upper_limit="1.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 20: PROMIS: EDD = 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.30" lower_limit="0.21" upper_limit="0.39"/>
                    <measurement group_id="O2" value="0.26" lower_limit="0.17" upper_limit="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 20: PROMIS: EDD = 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" lower_limit="0.32" upper_limit="0.46"/>
                    <measurement group_id="O2" value="0.31" lower_limit="0.23" upper_limit="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to Week 20: PROMIS: EDD = 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.48" lower_limit="0.39" upper_limit="0.56"/>
                    <measurement group_id="O2" value="0.36" lower_limit="0.27" upper_limit="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PROMIS: EDD measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.885</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PROMIS: EDD measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.319</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Anxiety Short Form (PROMIS: EDA)</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PROMIS: EDA is a 4-item questionnaire that measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Emotional Distress-Anxiety Short Form (PROMIS: EDA)</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PROMIS: EDA is a 4-item questionnaire that measures self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in the past seven days. Scores range 4-20, with higher scores representing more severe anxiety symptoms.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: PROMIS: EDA = 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.46" lower_limit="0.26" upper_limit="0.66"/>
                    <measurement group_id="O2" value="0.47" lower_limit="0.26" upper_limit="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: PROMIS: EDA = 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" lower_limit="0.68" upper_limit="1.01"/>
                    <measurement group_id="O2" value="0.83" lower_limit="0.66" upper_limit="0.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: PROMIS: EDA = 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.23" lower_limit="0.91" upper_limit="1.55"/>
                    <measurement group_id="O2" value="1.18" lower_limit="0.86" upper_limit="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: PROMIS: EDA = 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" lower_limit="0.16" upper_limit="0.35"/>
                    <measurement group_id="O2" value="0.18" lower_limit="0.08" upper_limit="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: PROMIS: EDA = 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.46" lower_limit="0.38" upper_limit="0.53"/>
                    <measurement group_id="O2" value="0.37" lower_limit="0.29" upper_limit="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: PROMIS: EDA = 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.66" lower_limit="0.50" upper_limit="0.81"/>
                    <measurement group_id="O2" value="0.56" lower_limit="0.40" upper_limit="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PROMIS: EDA measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.838</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PROMIS: EDA measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.890</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Ability to Participate in Social Roles and Activities Short Form (PROMIS: APRA)</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PROMIS: APRA is a 4-item questionnaire that measures the perceived ability to perform one's everyday social roles and activities. Scores range 4-20 with higher scores representing fewer limitations (greater abilities).</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Patient Reported Outcomes Measurement Information System (PROMIS): Ability to Participate in Social Roles and Activities Short Form (PROMIS: APRA)</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The PROMIS: APRA is a 4-item questionnaire that measures the perceived ability to perform one's everyday social roles and activities. Scores range 4-20 with higher scores representing fewer limitations (greater abilities).</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: PROMIS: APRA = 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.57" lower_limit="0.35" upper_limit="0.80"/>
                    <measurement group_id="O2" value="0.46" lower_limit="0.23" upper_limit="0.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: PROMIS: APRA = 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" lower_limit="0.60" upper_limit="0.89"/>
                    <measurement group_id="O2" value="0.73" lower_limit="0.58" upper_limit="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: PROMIS: APRA = 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.91" lower_limit="0.69" upper_limit="1.13"/>
                    <measurement group_id="O2" value="1.00" lower_limit="0.77" upper_limit="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: PROMIS: APRA = 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" lower_limit="0.23" upper_limit="0.44"/>
                    <measurement group_id="O2" value="0.24" lower_limit="0.13" upper_limit="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: PROMIS: APRA = 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" lower_limit="0.33" upper_limit="0.47"/>
                    <measurement group_id="O2" value="0.32" lower_limit="0.25" upper_limit="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: PROMIS: APRA = 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" lower_limit="0.36" upper_limit="0.58"/>
                    <measurement group_id="O2" value="0.41" lower_limit="0.30" upper_limit="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PROMIS: APRA measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.425</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PROMIS: APRA measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.733</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Five Facet Mindfulness Questionnaire (FFMQ) Abbreviated</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The FFMQ is a 39-item questionnaire that examines five aspects of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Only the questions related to non-judging of inner experience and non-reactivity were administered (15 items total). The total score on these 15 items was used (range: 15-75). Higher scores represent greater mindfulness.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Baseline Five Facet Mindfulness Questionnaire (FFMQ) Abbreviated</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. The FFMQ is a 39-item questionnaire that examines five aspects of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Only the questions related to non-judging of inner experience and non-reactivity were administered (15 items total). The total score on these 15 items was used (range: 15-75). Higher scores represent greater mindfulness.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: FFMQ = 40</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.06" lower_limit="0.85" upper_limit="1.26"/>
                    <measurement group_id="O2" value="0.97" lower_limit="0.75" upper_limit="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: FFMQ = 50</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" lower_limit="0.64" upper_limit="0.93"/>
                    <measurement group_id="O2" value="0.75" lower_limit="0.60" upper_limit="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: FFMQ = 60</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" lower_limit="0.32" upper_limit="0.70"/>
                    <measurement group_id="O2" value="0.53" lower_limit="0.34" upper_limit="0.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: FFMQ = 40</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.52" lower_limit="0.42" upper_limit="0.62"/>
                    <measurement group_id="O2" value="0.41" lower_limit="0.31" upper_limit="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: FFMQ = 50</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" lower_limit="0.34" upper_limit="0.48"/>
                    <measurement group_id="O2" value="0.33" lower_limit="0.25" upper_limit="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: FFMQ = 60</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.30" lower_limit="0.22" upper_limit="0.39"/>
                    <measurement group_id="O2" value="0.24" lower_limit="0.15" upper_limit="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>FFMQ measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.582</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>FFMQ measured at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.666</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Self-Reported Presence of Psychiatric Illness (Yes or No)</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported whether they have a psychiatric illness.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Self-Reported Presence of Psychiatric Illness (Yes or No)</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported whether they have a psychiatric illness.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: Psychiatric Illness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.86" lower_limit="0.59" upper_limit="1.13"/>
                    <measurement group_id="O2" value="0.68" lower_limit="0.40" upper_limit="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: No Psychiatric Illness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.75" lower_limit="0.57" upper_limit="0.92"/>
                    <measurement group_id="O2" value="0.79" lower_limit="0.60" upper_limit="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Psychiatric Illness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.86" lower_limit="0.86" upper_limit="0.86"/>
                    <measurement group_id="O2" value="0.68" lower_limit="0.68" upper_limit="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: No Psychiatric Illness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" lower_limit="0.29" upper_limit="0.46"/>
                    <measurement group_id="O2" value="0.32" lower_limit="0.24" upper_limit="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Presence of psychiatric illness at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.355</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Presence of psychiatric illness at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.361</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Self-Reported Presence of Medical Problems (Yes or No)</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported whether they have a major medical problem.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Self-Reported Presence of Medical Problems (Yes or No)</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported whether they have a major medical problem.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: Medical Problems</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" lower_limit="0.62" upper_limit="0.96"/>
                    <measurement group_id="O2" value="0.80" lower_limit="0.61" upper_limit="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: No Medical Problems</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" lower_limit="0.50" upper_limit="1.06"/>
                    <measurement group_id="O2" value="0.67" lower_limit="0.38" upper_limit="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Medical Problems</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" lower_limit="0.79" upper_limit="0.79"/>
                    <measurement group_id="O2" value="0.80" lower_limit="0.80" upper_limit="0.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: No Medical Problems</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.38" lower_limit="0.25" upper_limit="0.52"/>
                    <measurement group_id="O2" value="0.37" lower_limit="0.24" upper_limit="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Presence of medical problems at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.640</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Presence of medical problems at the beginning of the intervention period was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.396</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Percentage of Sessions Completed</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Percentage of total study sessions completed was calculated.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Percentage of Sessions Completed</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Percentage of total study sessions completed was calculated.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: 0%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" lower_limit="0.03" upper_limit="0.51"/>
                    <measurement group_id="O2" value="0.64" lower_limit="0.37" upper_limit="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: 33%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.61" lower_limit="0.45" upper_limit="0.77"/>
                    <measurement group_id="O2" value="0.70" lower_limit="0.52" upper_limit="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: 100%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.28" lower_limit="1.02" upper_limit="1.55"/>
                    <measurement group_id="O2" value="0.82" lower_limit="0.57" upper_limit="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: 0%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" lower_limit="0.14" upper_limit="0.37"/>
                    <measurement group_id="O2" value="0.26" lower_limit="0.14" upper_limit="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: 33%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" lower_limit="0.27" upper_limit="0.42"/>
                    <measurement group_id="O2" value="0.31" lower_limit="0.22" upper_limit="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: 100%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" lower_limit="0.41" upper_limit="0.65"/>
                    <measurement group_id="O2" value="0.39" lower_limit="0.28" upper_limit="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Percentage of sessions completed was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.004</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Percentage of sessions completed was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.291</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Education</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported their level of education.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Education</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported their level of education.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: High School or Less</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.38" lower_limit="-0.35" upper_limit="1.11"/>
                    <measurement group_id="O2" value="0.39" lower_limit="-0.31" upper_limit="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: 2 or 4-Year College</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.84" lower_limit="0.63" upper_limit="1.06"/>
                    <measurement group_id="O2" value="0.75" lower_limit="0.53" upper_limit="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: &gt; College</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.73" lower_limit="0.52" upper_limit="0.95"/>
                    <measurement group_id="O2" value="0.87" lower_limit="0.64" upper_limit="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: High School or Less</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" lower_limit="0.06" upper_limit="0.75"/>
                    <measurement group_id="O2" value="0.20" lower_limit="-0.15" upper_limit="0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: 2 or 4-Year College</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" lower_limit="0.34" upper_limit="0.54"/>
                    <measurement group_id="O2" value="0.31" lower_limit="0.20" upper_limit="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: &gt; College</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" lower_limit="0.27" upper_limit="0.46"/>
                    <measurement group_id="O2" value="0.37" lower_limit="0.27" upper_limit="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Level of education was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.603</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Level of education was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.333</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Race</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported their race.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Race</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported their race.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" lower_limit="0.66" upper_limit="0.97"/>
                    <measurement group_id="O2" value="0.77" lower_limit="0.61" upper_limit="0.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: Non-White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" lower_limit="-0.28" upper_limit="0.87"/>
                    <measurement group_id="O2" value="0.78" lower_limit="0.20" upper_limit="1.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" lower_limit="0.33" upper_limit="0.47"/>
                    <measurement group_id="O2" value="0.34" lower_limit="0.26" upper_limit="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Non-White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" lower_limit="0.15" upper_limit="0.67"/>
                    <measurement group_id="O2" value="0.37" lower_limit="0.10" upper_limit="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Race was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.224</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Race was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.885</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Sex</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported sex assigned at birth.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Sex</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported sex assigned at birth.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.49" lower_limit="0.18" upper_limit="0.81"/>
                    <measurement group_id="O2" value="0.51" lower_limit="0.17" upper_limit="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" lower_limit="0.68" upper_limit="1.01"/>
                    <measurement group_id="O2" value="0.82" lower_limit="0.65" upper_limit="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.85" lower_limit="-0.22" upper_limit="3.91"/>
                    <measurement group_id="O2" value="0.18" lower_limit="-1.58" upper_limit="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" lower_limit="0.13" upper_limit="0.41"/>
                    <measurement group_id="O2" value="0.27" lower_limit="0.12" upper_limit="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" lower_limit="0.37" upper_limit="0.52"/>
                    <measurement group_id="O2" value="0.35" lower_limit="0.26" upper_limit="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.29" lower_limit="0.34" upper_limit="2.24"/>
                    <measurement group_id="O2" value="0.34" lower_limit="-0.42" upper_limit="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Sex was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.490</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Sex was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.266</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Ethnicity</title>
        <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported their ethnicity.</description>
        <time_frame>Baseline to 8 Weeks, Baseline to 20 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mindfulness-Based Cognitive Therapy</title>
            <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
          </group>
          <group group_id="O2">
            <title>Brief Mindfulness</title>
            <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Weekly Change in World Health Organization-5 (WHO-5) Stratified by Ethnicity</title>
          <description>The WHO-5 is a 5-item questionnaire that assesses well-being over the prior two weeks. Scores range 0-100 with higher scores reflecting greater well-being. Participants reported their ethnicity.</description>
          <units>estimated weekly change in WHO-5 score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2220"/>
                <count group_id="O2" value="2192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 8 Weeks: Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.92" lower_limit="0.12" upper_limit="1.71"/>
                    <measurement group_id="O2" value="0.88" lower_limit="0.13" upper_limit="1.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: Non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" lower_limit="0.61" upper_limit="0.91"/>
                    <measurement group_id="O2" value="0.77" lower_limit="0.61" upper_limit="0.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 8 Weeks: Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.67" lower_limit="-3.14" upper_limit="4.48"/>
                    <measurement group_id="O2" value="0.68" lower_limit="-3.12" upper_limit="4.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.56" lower_limit="0.17" upper_limit="0.95"/>
                    <measurement group_id="O2" value="0.23" lower_limit="-0.13" upper_limit="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" lower_limit="0.33" upper_limit="0.47"/>
                    <measurement group_id="O2" value="0.34" lower_limit="0.27" upper_limit="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 20 Weeks: Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" lower_limit="-2.60" upper_limit="4.08"/>
                    <measurement group_id="O2" value="0.68" lower_limit="-2.66" upper_limit="4.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ethnicity was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 8.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.928</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ethnicity was analyzed as a moderator of the relationship between treatment and weekly WHO-5 scores. We added a main effect for the moderator, as well as treatment by time, moderator by time, and treatment by moderator by time interactions to the linear mixed model and used a likelihood ratio test to compare this interaction model to one without the three-way interaction. These analyses were completed over Baseline to Week 20.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.307</p_value>
            <p_value_desc>Reported p-value is for estimated weekly change in WHO-5 score by treatment by moderator interaction.</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>20 weeks.</time_frame>
      <desc>Data on adverse events (AEs) were collected with a 3-item questionnaire at all study sessions after study randomization. Participants provided a written description of the event, and three study staff sorted these into appropriate organ systems: two coded responses independently and the third resolved discrepancies. Participants reported the event severity, based on a plain-English definition of a serious adverse event (SAE). No AEs/SAEs were reported by participants to be study-related.</desc>
      <group_list>
        <group group_id="E1">
          <title>Mindfulness-Based Cognitive Therapy</title>
          <description>8 sessions of online mindfulness-based cognitive therapy&#xD;
Mindfulness-Based Cognitive Therapy: 8 sessions of online mindfulness-based cognitive therapy</description>
        </group>
        <group group_id="E2">
          <title>Brief Mindfulness</title>
          <description>3 sessions of online mindfulness therapy&#xD;
Brief Mindfulness: 3 sessions of online mindfulness therapy</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2220"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="2220"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Blood/Lymphatic Issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal Issue</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2220"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Undefined Health Issue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2220"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Immune System Issue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal or Connective Tissue Issue</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2220"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Nervous System Issue</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychiatric Issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory Issue/Flu</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2220"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Negative Life Event</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="2220"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Surgical or Medical Procedure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="2220"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Blood or Lymphatic Issue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine Issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Vision/Eye Issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal Issue</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2220"/>
                <counts group_id="E2" events="14" subjects_affected="10" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Undefined Health Issue</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="2220"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Immune System Issue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Injury or Procedural Complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2220"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2192"/>
              </event>
              <event>
                <sub_title>Injury or Procedural Complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal or Connective Tissue Issue</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="2220"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Nervous System Issue</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Medication Side-Effect</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychiatric Issue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2220"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Reproductive Issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory Issue/Flu</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin Condition</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2220"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Negative Life Event</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Surgical or Medical Procedure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2220"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular Issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2220"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2192"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Despite having a wide range of clinical and non-clinical samples represented in this study, the sample generalizability was limited in regards to race and gender. A second limitation was not including support for participants to access the study (e.g., technical support, translated versions into other languages) as well as to engage with the study interventions.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Andrew Nierenberg</name_or_title>
      <organization>Massachusetts General Hospital</organization>
      <phone>617-512-2641</phone>
      <email>anierenberg@mgh.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

